Comparative Efficacy of Curative Effects of Sacubitril/Valsartan in HFpEF versus HFrEF Treatment
CONCLUSIONS: Sacubitril/Valsartan demonstrates superior efficacy in improving renal function and enhancing quality of life in HFpEF patients while providing comparable prognostic benefits for HFrEF patients. This finding underscores its potential as a therapeutic foundation in the management of heart failure across ejection fraction categories.PMID:38430177
Source: Alternative Therapies in Health and Medicine - Category: Complementary Medicine Authors: Yi Li Zifan Zhu Hongbin Liu Source Type: research
More News: Alternative and Complementary Therapies | Cardiology | Complementary Medicine | Diovan | Heart | Heart Failure | Statistics | Study